NASDAQ:PIII

P3 Health Partners (PIII) Stock Forecast, Price & News

$1.38

-0.07 (-4.83%)

(As of 09/28/2023 ET)

Compare

Today's Range: $1.38
▼
$1.46
50-Day Range: $1.31
▼
$2.79
52-Week Range: $0.70
▼
$6.02

Volume: 283,984 shs
Average Volume: 461,629 shs
Market Capitalization: $431.50 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.00

P3 Health Partners MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 262.3% Upside
$5.00 Price Target
Short Interest: Bearish
8.54% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.30
Based on 2 Articles This Week
Insider Trading: Acquiring Shares
$1.43 M Bought Last Quarter
Proj. Earnings Growth: Growing
From ($0.96) to ($0.73) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.94 out of 5 stars

Medical Sector

689th out of 970 stocks

Health Services Industry

8th out of 14 stocks

3.3

Analyst's Opinion

Consensus Rating
P3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $5.00, P3 Health Partners has a forecasted upside of 262.3% from its current price of $1.38.
Amount of Analyst Coverage
P3 Health Partners has only been the subject of 1 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
8.54% of the float of P3 Health Partners has been sold short.
Short Interest Ratio / Days to Cover
P3 Health Partners has a short interest ratio ("days to cover") of 8.8.
Change versus previous month
Short interest in P3 Health Partners has recently increased by 36.18%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
P3 Health Partners does not currently pay a dividend.
Dividend Growth
P3 Health Partners does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for PIII.

2.9

News and Social Media Coverage

News Sentiment
P3 Health Partners has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for P3 Health Partners this week, compared to 1 article on an average week.
Search Interest
15 people have searched for PIII on MarketBeat in the last 30 days. This is an increase of 36% compared to the previous 30 days.
MarketBeat Follows
9 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, P3 Health Partners insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,427,400.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
17.06% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 23.57% of the stock of P3 Health Partners is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for P3 Health Partners are expected to grow in the coming year, from ($0.96) to ($0.73) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of P3 Health Partners is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of P3 Health Partners is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
P3 Health Partners has a P/B Ratio of 9.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About P3 Health Partners (NASDAQ:PIII) Stock

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

PIII Price History

30 days | 90 days | 365 days | Advanced Chart

PIII Stock News Headlines

September 14, 2023 | finance.yahoo.com

Chicago Pacific Founders UGP III, LLC Buys 270,000 Shares of P3 Health Partners Inc

September 12, 2023 | markets.businessinsider.com

BTIG Keeps Their Buy Rating on P3 Health Partners (PIII)

September 29, 2023 | Tradewins (Ad)

Successful Options Trading Begins With…

Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month!

September 10, 2023 | seekingalpha.com

P3 Health Partners: Right Place, Right Time, Wrong Horse To Back?

September 1, 2023 | msn.com

BTIG Initiates Coverage of P3 Health Partners Inc - (PIII) with Buy Recommendation

August 8, 2023 | finance.yahoo.com

At US$2.14, Is P3 Health Partners Inc. (NASDAQ:PIII) Worth Looking At Closely?

July 28, 2023 | finance.yahoo.com

P3 Health Partners Schedules Second-Quarter 2023 Earnings Release and Conference Call

July 19, 2023 | finance.yahoo.com

A Look At The Fair Value Of P3 Health Partners Inc. (NASDAQ:PIII)

September 29, 2023 | Tradewins (Ad)

Successful Options Trading Begins With…

July 10, 2023 | benzinga.com

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating P3 Health Partners Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

July 6, 2023 | msn.com

P3 Health Partners Inc - (PIII) Price Target Decreased by 15.38% to 5.61

June 15, 2023 | seekingalpha.com

P3 Health Partners On Solid Path To Profitability

June 9, 2023 | seekingalpha.com

P3 Health Partners: Just Another SPAC-Listed 'Value-Based Care' Company?

June 1, 2023 | msn.com

Why Shares of P3 Health Partners Soared This Week

May 17, 2023 | benzinga.com

Chief Executive Officer At This Health Care Company Buys $284K of Stock

May 17, 2023 | msn.com

Why P3 Healthcare Shares Jumped Wednesday

May 16, 2023 | finance.yahoo.com

P3 Health Partners Inc. (NASDAQ:PIII) Q1 2023 Earnings Call Transcript

May 10, 2023 | finance.yahoo.com

P3 Health Partners Announces First-Quarter 2023 Results

May 3, 2023 | msn.com

Here Is Why Bargain Hunters Would Love Fast-paced Mover P3 Health Partners Inc. (PIII)

May 2, 2023 | finance.yahoo.com

P3 Health Partners Schedules First-Quarter 2023 Earnings Release and Conference Call

May 1, 2023 | msn.com

P3 Health (NASDAQ:PIII) Stock Gains on $5.6M Insider Buy

April 19, 2023 | marketwatch.com

P3 Health Partners Inc. (“P3”) had Impressive 2022 Year-End Results with Capitated Revenue of approximately $1 Billion Dollars; PIII

March 30, 2023 | finance.yahoo.com

P3 Health Partners Announces Date Change for Fourth-Quarter and Full-Year 2022 Earnings Call

March 24, 2023 | finance.yahoo.com

P3 Health Partners to Report Fourth-Quarter and Full-Year 2022 Financial Results on March 30

March 14, 2023 | finance.yahoo.com

P3 Health Partners Affirms 2023 Outlook and Schedules Earnings Call for 2022 Results

March 9, 2023 | finance.yahoo.com

P3 Health Partners Executive to Present at Upcoming Investor Conferences

January 23, 2023 | uk.news.yahoo.com

P3 Health Partners Inc. (NASDAQ:PIII) drops to US$375m and insiders who purchased earlier this year lose another US$51k

See More Headlines

Receive PIII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter.

PIII Company Calendar

Last Earnings: 8/07/2023
Today: 9/29/2023
Next Earnings (Estimated): 11/13/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health services
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:PIII
CUSIP: N/A
CIK: 1832511
Web: foresightacq.com
Phone: 702-910-3950
Fax: N/A
Employees: 600
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $5.00
High Stock Price Forecast: $5.00
Low Stock Price Forecast: $5.00
Forecasted Upside/Downside: +262.3%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2,260.8101)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-270,130,000.00
Net Margins: -10.92%
Pretax Margin: -59.36%
Return on Equity: -2,471.27%
Return on Assets: 33.63%

Debt

Debt-to-Equity Ratio: 16.13
Current Ratio: 0.69
Quick Ratio: 0.69

Sales & Book Value

Annual Sales: $1.05 billion
Price / Sales: 0.41
Cash Flow: $34.50 per share
Price / Cash Flow: 0.04
Book Value: $0.15 per share
Price / Book: 9.20

Miscellaneous

Outstanding Shares: 312,680,000
Free Float: 259,334,000
Market Cap: $431.50 million
Optionable: Not Optionable
Beta: 1.25

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Sherif Abdou F.A.C.E.P. (Age 62)
FACP, M.D., Co-Founder, CEO & Director
Comp: $7.1M

Dr. Amir Bacchus M.B.A. (Age 58)
M.D., Co-Founder, Chief Medical Officer & Director
Comp: $4.3M

Mr. Atul Kavthekar
CFO & Chief Accounting Officer

Mr. William Bettermann
Exec. VP & COO

Mr. Devery Goodey
Sr. VP of Technology

Ms. Karen Blomquist
VP of Investor Relations

Ms. Jessica Puathasnanon
Chief Legal Officer, Gen. Counsel & Sec.

Ms. Kassi Belz APR
Exec. VP of Communications, Culture & Engagement

Ms. Lorie Glisson CPA
Florida Market Pres

Mr. Todd Lefkowitz MHA
Chief Managed Care Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

PIII Stock - Frequently Asked Questions

Should I buy or sell P3 Health Partners stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PIII shares.
View PIII analyst ratings or view top-rated stocks.
What is P3 Health Partners' stock price forecast for 2023?: 2 brokers have issued 1-year target prices for P3 Health Partners' stock. Their PIII share price forecasts range from $5.00 to $5.00. On average, they expect the company's stock price to reach $5.00 in the next year. This suggests a possible upside of 262.3% from the stock's current price.
View analysts price targets for PIII or view top-rated stocks among Wall Street analysts.
How have PIII shares performed in 2023?: P3 Health Partners' stock was trading at $1.84 at the beginning of 2023. Since then, PIII shares have decreased by 25.0% and is now trading at $1.38.
View the best growth stocks for 2023 here.
Are investors shorting P3 Health Partners?: P3 Health Partners saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 4,140,000 shares, an increase of 36.2% from the August 31st total of 3,040,000 shares. Based on an average daily trading volume, of 472,000 shares, the short-interest ratio is presently 8.8 days. Currently, 8.5% of the shares of the stock are short sold.
View P3 Health Partners' Short Interest.
When is P3 Health Partners' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our PIII earnings forecast.
How were P3 Health Partners' earnings last quarter?: P3 Health Partners Inc. (NASDAQ:PIII) announced its earnings results on Monday, August, 7th. The company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.24) by $0.15. The company earned $329.09 million during the quarter, compared to the consensus estimate of $303.30 million. P3 Health Partners had a negative net margin of 10.92% and a negative trailing twelve-month return on equity of 2,471.27%.

What guidance has P3 Health Partners issued on next quarter's earnings?: P3 Health Partners updated its FY 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.20 billion-$1.25 billion, compared to the consensus revenue estimate of $1.24 billion.
What is P3 Health Partners' stock symbol?: P3 Health Partners trades on the NASDAQ under the ticker symbol "PIII."
How do I buy shares of P3 Health Partners?: Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is P3 Health Partners' stock price today?: One share of PIII stock can currently be purchased for approximately $1.38.
How much money does P3 Health Partners make?: P3 Health Partners (NASDAQ:PIII) has a market capitalization of $431.50 million and generates $1.05 billion in revenue each year. The company earns $-270,130,000.00 in net income (profit) each year or ($2,260.8101) on an earnings per share basis.
How many employees does P3 Health Partners have?: The company employs 600 workers across the globe.
How can I contact P3 Health Partners?: P3 Health Partners' mailing address is 2045 W GRAND AVE STUITE B, CHICAGO IL, 60612. The official website for the company is foresightacq.com. The company can be reached via phone at 702-910-3950 or via email at shalper@lifesciadvisors.com.

This page (NASDAQ:PIII) was last updated on 9/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial